Trials / Recruiting
RecruitingNCT05842902
Resilience Mobile App for Teens and Young Adults With Cancer
Pilot Trial Testing Mobile Health Psychosocial Intervention for Adolescents and Young Adults With Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Seattle Children's Hospital · Academic / Other
- Sex
- All
- Age
- 12 Years – 25 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this pilot trial is to examine whether a mobile app version of the Promoting Resilience in Stress Management (PRISM) intervention is acceptable, easy to use, and helps improve quality of life and mental health symptoms.
Detailed description
Adolescents and Young Adults (AYAs) with cancer are at risk of distress, anxiety, depression, and poor quality of life. The use of mobile applications for psychosocial symptom self-management is appealing to this demographic population but this has not yet been developed and tested. PRISM is a novel, brief, evidence-based 1:1 intervention that teaches stress management, goal-setting, meaning making, cognitive-behavioral, and mindfulness strategies. Here, we propose to test a mobile health (mHealth) version of PRISM, mPRISM. In a pilot randomized controlled trial, we will evaluate the feasibility, acceptability, and exploratory efficacy of mPRISM using a waitlist control design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | mPRISM | PRISM is a brief, 1:1, skills-based resilience intervention delivered in-person by trained layperson coaches. PRISM's development was based on iterative research within the AYA oncology population, stress and coping theory, resilience theory, and successful cognitive-behavioral and mindfulness interventions. mPRISM is a digital version of the PRISM program with no in-person delivery. mPRISM includes coping skills modules: managing stress, goal-setting, cognitive reframing, and meaning-making. |
Timeline
- Start date
- 2023-09-12
- Primary completion
- 2027-06-01
- Completion
- 2027-06-01
- First posted
- 2023-05-06
- Last updated
- 2025-07-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05842902. Inclusion in this directory is not an endorsement.